The Thromboelastography (TEG) market comprises of devices, reagents and services required for performing thromboelastography, a diagnostic test that measures blood clotting. This market is specifically focused on technologies for acquiring the complete picture of the clot formation and its stability. TEG is most important in the fields of peri-operative and intensive care where coagulation status is constantly monitored and couples with appropriate management. They are used in controlling bleeding problems and other kinds of thrombotic disorders making them essential in the hospital, diagnostic centre, and surgical units.

The market for thromboelastography is experiencing steady growth in recent years predominantly due to growing incidences of cardiovascular and coagulation diseases. Due to higher numbers of surgeries and trauma cases globally, there has been escalating need of prompt and accurate measures of coagulation which makes TEG more favorable. Moreover, the increasing consciousness about blood clot analysis in surgeries, especially in complications that may be experienced during and after the surgeries, has also increased the rate of TEG adopted in medical facilities. It is anticipated that the growth of thromboelastography market extend with hospitals and clinic’s understanding the advantages of minimizing blood product request, and enhancing patient care.

Another important driving force for TEG market is increasing efficiency of thermos electric generators due to novelties in the TEG gadgets that have higher accuracy up to their usage. As there is always focus towards reduction of complications related to blood transfusion in this healthcare sector, more and more point of care coagulation monitoring systems such as TEG have been adopted. Moreover, advanced healthcare facilities in new markets as well as newly introduced portable TEG analysers can form new horizons to new markets and regions including both developed and developing countries. With more advanced hospitals and increasing patient education, the market for thromboelastography remains to be promising.

Thromboelastography Market Trend Analysis:

Technological Innovations Driving Market Trends

• The thromboelastography market exhibits constant technological improvements in that newer devices offer increased diagnostic consistency and ease of use. New generation, portable and point-of-use TEG devices enable bedside testing and are especially beneficial in emergency and intensive care. These developments enhance the convenience of coagulation tests, to improve decisions in trauma surgery and emergent operations. Furthermore, latest models of TEG devices are; in some they can be integrated with Hospital Information System-HIS in order to enhance records keeping and analysis for improved clinical decisions.

• One of the trends defining the market is the use of artificial intelligence (AI) in TEG devices. These devices should be able to analyse patient data, offer prognoses, and possibly offer interpretation on its own, thus shifting a percentage of workload from health care professionals. AI incorporated TEG solutions should prove helpful in improving patient management particularly coagulopathies with nuanced acumen which needs the analyses afforded by the technology. In future, as the AI technology develops, its incorporation for use in the TEG devices may diametrically transform coagulation diagnose, improving therefore its speed as well as accuracy in inter-related smartphone applications across multiplicity of health care facilities.

Emerging Opportunities in Untapped Markets

• The prominent growth rates are characteristic of emerging markets concerning thromboelastography. In Asia-Pacific, Latin America, Middle East, the demand for TEG is fuelled by the rising incidence of cardiovascular diseases, and the growth of the health care industry. These regions are therefore facing increasing need for diagnostic solutions to meet coagulation challenges in the shortest time possible.

• Bureaucrats in the fields of healthcare as well as governmental institutions are actively enhancing the utilization of the TEG as well as other enhanced diagnostic apparatus to promote positive and more effective patient health care without increasing levels of health risks due to subpar coagulation management.

Thromboelastography Market Segment Analysis:

Thromboelastography Market is Segmented on the basis of Type, Application, End User and Region.

By Type, Single and Double Channel segment is expected to dominate the market during the forecast period

• The Single and Double Channel segment is likely to reign the thromboelastography market throughout the referenced timeframe prevalently employed in critical and emergency care. These channel types provide convenience and speed with which healthcare providers conducting coagulation tests can analyze the formation of clots in the blood, with little preparation. These single-channel devices are highly preferred in small health-care facilities and are also suitable for outpatient clinics because these machines consume little space and energy.

• Double-channel devices are wanted in the largish hospital and trauma centres where there is need to respond to a high number of patients and where many tests are required at once. This growing demand for fast and accurate coagulation monitoring especially during surgeries and emergency treatments boosted the market of these channel configurations making them the market leaders.

By Application, Liver Surgery segment expected to held the largest share

• The Liver Surgery segment is expected to dominate the thromboelastography market in terms of its application because surgical procedures involving the liver require efficient coagulation control. Many liver-surgical procedures are massive liver resections or liver transplants, which lead to important blood loss with concomitant elevated thromboembolic risk necessitating the requirement for real-time coagulation profile delineation.

• Thromboelastometry is a tool for surgeons and anaesthesiologists to review a patient’s coagulation status and management of bleeding appropriately with blood components or fibrinolytic products in case of need. The growth in average age, the related liver diseases, the demand for liver transplant and the focus on better quality and fewer complications in surgery by using TEG devices also strengthens this segment.

Thromboelastography Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America is leading the thromboelastography market because this region has an improved healthcare system and technology integration in diagnostic devices. Among these, the USA emerges as the market leader in this region dominating a significant proportion of the global TEG market. The reasons for this dominance is continued improvement in understanding by the healthcare practitioners of TEG and the patients towards the enhancement in the understanding of the benefits of TEG in the management of coagulation disorders.  The region witnesses a high number of surgical procedures, traumatological cases, and beginners make a purchase; however, advanced market players are mainly also based in North America.

Active Key Players in the Thromboelastography Market

• Abbott Laboratories (United States)

• Biomérieux SA (France)
• Danaher Corporation (United States)
• Entegrion, Inc. (United States)
• Fresenius Kabi (Germany)
• Haemonetics Corporation (United States)
• HemoSonics (United States)
• Instrumentation Laboratory (United States)
• LivaNova (United Kingdom)
• Medtronic (Ireland)
• Roche Diagnostics (Switzerland)
• Siemens Healthineers (Germany)
• Sienco, Inc. (United States)
• Stago (France)
• Terumo Corporation (Japan)

DOWNLOAD THE SAMPLE REPORT
https://introspectivemarketresearch.com/request/20060

CONTACT US:-

INTROSPECTIVR MARKET RESEARCH
CALL:- +91 91753-37569.
Email:- [email protected]
Website:- https://introspectivemarketresearch.com/